Here are four insights:
1. The more than 8 million shares of common stock were priced at $15 per share to the public.
2. All offered by SI-Bone, the shares began trading on the NASDAQ global market Oct. 17.
3. In celebration of the shares going public, SI-Bone CEO and President Jeffrey Dunn rang the opening bell at the New York City-based NASDAQ MarketSite in Times Square Nov. 30.
4. SI-Bone created the iFuse Implant System, which is a minimally invasive surgical system designed to fuse the sacroiliac joint to treat sacroiliac joint dysfunction.
More articles on devices and implants:
Medtronic CEO Omar Ishrak visits Israel among recent, potential new acquisitions: 5 things to know
Exparel launches patient education website with non-opioid pain management information, resources
Former Zimmer Biomet SVP loses bid for severance in court: 5 insights
